| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |